Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 14.35 | 47.11 | ||
| High | 32.50 | 14.35 | 47.11 | ||
| Low | 32.48 | 14.35 | 47.11 | ||
| Latest | 32.48 | 14.35 | 47.11 | ||
| Change | +0.01 | +0.59 | -0.65 | ||
| % Change | +0.03% | +4.29% | -1.36% | ||
| Volume | 8,356,200 | 455,680 | 331 | ||
| 20-Day Average Volume | 3,390,805 | 2,077,569 | 859,722 | ||
| Previous Close | 32.47 | 13.76 | 47.76 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 14.31 | 52.45 | ||
| 20-Day Raw Stochastic | 94.12% | 57.14% | 2.18% | ||
| 20-Day Relative Strength | 78.00 | 53.01 | 37.65 | ||
| Weighted Alpha | +247.60 | +7.11 | +36.94 | ||
| Today's Opinion | 100% Buy | 40% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 40% Sell | 24% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | +2.14% since 03/16/26 | -6.17% since 03/16/26 | ||
| Low | 32.44 on 03/15/24 | 13.75 on 03/20/26 | 46.83 on 03/20/26 | ||
| High | 32.50 on 03/21/24 | 14.35 on 03/23/26 | 51.15 on 03/17/26 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -2.38% since 02/23/26 | -7.06% since 02/23/26 | ||
| Low | 32.15 on 02/22/24 | 13.75 on 03/20/26 | 46.83 on 03/20/26 | ||
| High | 32.50 on 03/21/24 | 14.80 on 02/25/26 | 59.68 on 02/25/26 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | +0.84% since 12/23/25 | -8.90% since 12/23/25 | ||
| Low | 22.11 on 01/26/24 | 12.81 on 01/20/26 | 46.83 on 03/20/26 | ||
| High | 32.50 on 03/21/24 | 14.80 on 02/25/26 | 59.68 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -1.10% since 09/23/25 | +0.60% since 09/23/25 | ||
| Low | 12.32 on 10/13/23 | 12.81 on 01/20/26 | 43.11 on 11/05/25 | ||
| High | 32.50 on 03/21/24 | 14.95 on 10/22/25 | 59.68 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 11,484,564 | 2,750,116 | ||
| Shares Outstanding, K | 114,724 | 834,634 | 57,582 | ||
| Annual Sales | 31,070,000 | 3,811,000,000 | 718,950,000 | ||
| Annual Net Income | -105,370,000 | 663,000,000 | -38,550,000 | ||
| Last Quarter Sales | 60,000 | 977,400,000 | 211,570,000 | ||
| Last Quarter Net Income | -41,900,000 | 135,500,000 | -4,110,000 | ||
| 60-Month Beta | 0.32 | 0.34 | 0.70 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.16 on 01/21/26 | 0.92 on 02/24/26 | ||
| Latest Earnings Date | 05/20/24 | 05/08/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/25/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.36 | 21.52 | ||